Ondansentron and Dexamethasone Treatment with Different Dosing Schedules (24 versus 32 mg) in Patients with Non-Small-Cell Lung Cancer under Cisplatin-Based Chemotherapy:A Randomized Stud y

The purpose of this study was to determine whether ondansentron given to patients with non-small-cell lung cancer (NSCLC) undergoing cisplatin-based chemotherapy, has better antiemetic activity administered every 6 or 8 h in controlling cisplatin-induced emesis. All patients had previously received...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Chemotherapy (Basel) 2000-09, Vol.46 (5), p.364-370
Hauptverfasser:	Tsavaris, N., Kosmas, Ch, Vadiaka, M., Kanelopoulos, P., Kontos, A., Katsorida, M., Agelopoulou, A., Vrizidis, N., Fotia, M., Papoutsis, K., Koufos, Ch
Format:	Artikel
Sprache:	eng
Schlagworte:	Clinical Report
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!